about
Wnt/beta-catenin signaling and small molecule inhibitorsCell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomenaSelecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane ProteinsThe cancer stem cell niche--there goes the neighborhood?A novel kind of tumor type-characteristic junction: plakophilin-2 as a major protein of adherens junctions in cardiac myxomataDisorganized vascular structures in sporadic venous malformations: a possible correlation with balancing effect between Tie2 and TGF-β.N-cadherin in neuroblastoma disease: expression and clinical significance.Effects of Morphology vs. Cell-Cell Interactions on Endothelial Cell Stiffness.Anti-cadherin-17 antibody modulates beta-catenin signaling and tumorigenicity of hepatocellular carcinoma.p42.3 promotes cell proliferation and invasion in human Renal-Cell Carcinoma.Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactions.Ex Vivo Maintenance of Primary Human Multiple Myeloma Cells through the Optimization of the Osteoblastic Niche.E-N-cadherin heterodimers define novel adherens junctions connecting endoderm-derived cells.Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transitionProstaglandins in cancer cell adhesion, migration, and invasionEpidermal Growth Factor Receptor Mutation Enhances Expression of Cadherin-5 in Lung Cancer CellsCelastrus orbiculatus extract inhibits the migration and invasion of human glioblastoma cells in vitro.Androgen regulation of epithelial-mesenchymal transition in prostate tumorigenesisHitting Them Where They Live: Targeting the Glioblastoma Perivascular Stem Cell Niche.Emerging drugs for treating skeletal muscle injury and promoting muscle repair.Discovery and development of N-cadherin antagonists.Cell adhesion molecules and their relation to (cancer) cell stemness.N-cadherin antagonists as oncology therapeuticsCadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.Overexpression of p42.3 promotes cell proliferation, migration, and invasion in human gastric cancer cells.N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation.Role of C9orf140 in the promotion of colorectal cancer progression and mechanisms of its upregulation via activation of STAT5, β-catenin and EZH2.Upregulated expression levels of ADAM10 and EGFR and downregulated expression levels of E-cadherin in hepatocellular carcinomas.Decreased interleukin-20 level in patients with systemic sclerosis: are they related with angiogenesis?Cell adhesion molecules in metastatic neuroblastoma models.Serum replacement with albumin-associated lipids prevents excess aggregation and enhances growth of induced pluripotent stem cells in suspension culture.Isolation of a new cell population in the glioblastoma microenvironment.Hypoxia activates cadherin-22 synthesis via eIF4E2 to drive cancer cell migration, invasion and adhesion.Homeobox B3 promotes tumor cell proliferation and invasion in glioblastoma.Up-regulated N-cadherin expression is associated with poor prognosis in epithelial-derived solid tumors: a meta-analysis.
P2860
Q24597197-D303F07F-2D62-4214-A09F-6F7E20ABBB4CQ26860953-45A09684-6F96-49BB-9A5D-1C151000A6A6Q28077999-ACC193B1-357F-425A-A50B-68B79D376B8EQ28244178-296D4605-C383-4FFA-8028-44BAA2234114Q28289967-B7038D29-7036-4076-8E29-43182AB34D1DQ33807944-DFD95983-C883-4AA2-BE7D-A382F3E803DCQ34166281-48F54D7B-DCAC-4AAB-9598-8F6E8E63F457Q34602126-DCB0823E-3B83-4991-99FF-3A3454F8B974Q34988368-F0C577C2-7C70-4814-9F0D-60D9B8C52B86Q35017015-2DC1E260-EACD-46F6-AF01-810F762FCE7CQ35547645-AD24F1CF-53AE-41F9-84F6-AC028794B1DDQ35631433-0A819AE2-B656-41C8-922B-02EBB6E9DD80Q35670742-76ECACAC-939D-42C1-8508-10A5104A5390Q35774096-ECD4624F-3C4D-4E81-9F25-C5EC352AE2A0Q35821653-4B06D328-2EB3-4A0F-8A8D-54D21FEDF361Q36065121-FADAFA1C-6203-49C3-BD4B-25729CD4DD76Q36157355-B866E858-2BBB-4FC7-B271-C40E7D42DEC4Q36827512-97D8A10F-0650-4A27-B61C-488E59E8B172Q36916624-FC40D02B-E2CF-4331-AC9C-783B030E2421Q37842502-20A577E5-3849-4E01-9E1F-FE9296FBF9AEQ37979117-6B665D0A-787A-4441-90CF-44A884C53C49Q38188463-708462C5-8041-4D49-AE62-9B7EB735AAB9Q38297504-78BAF240-CECE-462D-BFA8-278A9AC820D8Q38669394-CF0313F6-F355-4371-9451-F9394D599053Q38736916-EF9242BE-79DA-4091-A954-9519E215D34BQ38949755-2E48A6EB-1E08-4BCF-8B34-B5698D860BDBQ39017365-FDE5D1A3-FD7F-4F49-A807-A0AC9F0CC091Q42077189-C375B6C2-D69D-405E-9039-E4CECB395AA1Q45854756-66A5F93A-F3CE-4617-9111-E42AD4F37CF8Q45862626-1C8D4E03-F3F7-41F8-869B-5D69C73635F0Q47794085-D3990B5B-4040-4976-855A-2F944E453BE9Q48891673-5C77B767-442A-4B0E-97A3-50AEC01535F9Q49391561-48861A48-F74B-4499-9FA7-FE808BF78DB6Q49874872-2092216B-DECB-466C-B546-4CCCD8B8F139Q50190878-7A79E814-FF01-405E-AE70-A24E246009D7
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cadherins as novel targets for anti-cancer therapy.
@en
Cadherins as novel targets for anti-cancer therapy.
@nl
type
label
Cadherins as novel targets for anti-cancer therapy.
@en
Cadherins as novel targets for anti-cancer therapy.
@nl
prefLabel
Cadherins as novel targets for anti-cancer therapy.
@en
Cadherins as novel targets for anti-cancer therapy.
@nl
P1476
Cadherins as novel targets for anti-cancer therapy.
@en
P2093
Emmanuelle Devemy
Orest W Blaschuk
P304
P356
10.1016/J.EJPHAR.2009.05.033
P407
P577
2009-10-16T00:00:00Z